Stay updated on Pembrolizumab for Metastatic Anal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, indicating the page has been revised. This reflects an updated version of the ClinicalTrials.gov study record page.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision: v3.6.5 replaces v3.6.4 to reflect a newer page build. This indicates a minor maintenance/patch applied to the page.SummaryDifference0.1%

- Check44 days agoChange DetectedThe footer revision label was updated from v3.6.3 to v3.6.4, indicating a new site release rather than a change to study details or functionality.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, indicating a minor site update without changes to the study details.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page now displays an updated revision identifier (v3.6.2), replacing the previous v3.6.0, indicating a minor platform version update.SummaryDifference0.1%

- Check87 days agoChange DetectedThe study page now shows recruitment status as 'No longer looking for participants', and adds help sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The 'Intervention/Treatment' heading formatting has changed and the site revision tag updated to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab for Metastatic Anal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page.